Olivenol® Subjectof Arthritis Study

Olivenol® Subjectof Arthritis Study

PHOENIXA scientific human studyunderway at the Arizona Biodesign Institute at Arizona State University (ASU) isinvestigating the effects of Olivenol® on rheumatoid arthritis (RA) andosteoarthritis (OA).

Approximately 100 RA and OA patients will be involved in theeight-week study, which will test whether Olivenol can increase mobility andminimize pain by decreasing swelling of the joints and inflammation of thesurrounding muscles, tendons and tissues.

CreAgri Inc. is the primary sponsor of the study, and issupplying Olivenol, which contains the active ingredient HIDROX, a richsource of the antioxidant hydroxytyrosol. We are very pleased and excited bythis collaboration with ASU and the Arizona Biodesign Institute, said RobertoCrea, founder and chief executive officer of CreAgri. The results of thisstudy could influence the medical community to review Olivenol, and its activeingredient HIDROX, as a potential safe and effective treatment to alleviate thesymptoms of RA and OA. It may serve as an alternative or a complement to drugsthat are more expensive and have numerous side effects.

For more information, visit www.creagri.com or Booth #1805 atSupplySide West.